This 18-month program offers a structured path into the pharmaceutical field with a focus on identifying patients with Friedreich Ataxia among neurologists and general practitioners.
Base: Minimum 48,000.00 EUR annually; Bonus/Equity: Not specified; Benefits: Company car (private use), housing cost support
Must-have
Nice-to-have
Not specified